Australia Healthcare Contract Development And Manufacturing Organization Market Size & Outlook
- HC Outsourcing
- CMO/CDMO
- Healthcare Contract Development And Manufacturing Organization Market Outlook
- CMO/CDMO
Global Market
Related Markets
Ask a question about the healthcare contract development and manufacturing organization market
Australia healthcare contract development and manufacturing organization market highlights
- The Australia healthcare contract development and manufacturing organization market generated a revenue of USD 5,610.8 million in 2024 and is expected to reach USD 14,013.1 million by 2033.
- The Australia market is expected to grow at a CAGR of 10.9% from 2025 to 2033.
- In terms of segment, medical device was the largest revenue generating type in 2024.
- Medical Device is the most lucrative type segment registering the fastest growth during the forecast period.
Healthcare contract development and manufacturing organization market data book summary
| Market revenue in 2024 | USD 5,610.8 million |
| Market revenue in 2033 | USD 14,013.1 million |
| Growth rate | 10.9% (CAGR from 2025 to 2033) |
| Largest segment | Medical device |
| Fastest growing segment | Medical Device |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule, Medical Device |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
Other key industry trends
- In terms of revenue, Australia accounted for 2.0% of the global healthcare contract development and manufacturing organization market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China healthcare contract development and manufacturing organization market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 87,245.0 million by 2033.
In Australia, there are nearly 400 domestic biotechnology, 500 MedTech, and 50 multinational companies operating as subsidiaries, including Pfizer, GSK, Bristol-Myers Squibb, Merck, and Novartis. Presence of a large number of local and foreign companies is anticipated to boost manufacturing activities, thereby fueling the market.
Furthermore, aligning with GMPs across various jurisdictions by the Australian Therapeutic Goods Administration (TGA), the U.S. FDA, and the EMA is anticipated to facilitate the market entry of U.S. and European firms in the country.
No credit card required*
Publish Date: Sep 16, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Healthcare Contract Development And Manufacturing Organization Market Scope
Healthcare Contract Development And Manufacturing Organization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lonza Group Ltd | View profile | 18,000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | www.lonza.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Jabil Inc | View profile | 236,000 | 10800 Roosevelt Boulevard North, Saint Petersburg, FL, United States, 33716 | www.jabil.com |
| Catalent Inc | View profile | 17,219 | 14 Schoolhouse Road, Somerset, NJ, United States, 08873 | www.catalent.com |
| Siegfried Holding AG | View profile | 4,180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | www.siegfried.ch |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | drugdevelopment.labcorp.com |
| IQVIA Holdings Inc | View profile | 87,000 | 2400 Ellis Road, Durham, NC, United States, 27703 | www.iqvia.com |
| Ajinomoto Co Inc | View profile | 43,318 | 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo, Japan, 104-8315 | www.ajinomoto.co.jp |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | www.recipharm.com |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | www.vetter-pharma.com/en |
Australia Healthcare Contract Development And Manufacturing Organization Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Healthcare Contract Development And Manufacturing Organization Market Outlook will help companies and investors design strategic landscapes.
Medical Device was the largest segment with a revenue share of 48.8% in 2024.
Horizon Databook has segmented the Australia healthcare contract development and manufacturing organization market based on small molecule, large molecule, medical device covering the revenue growth of each sub-segment from 2021 to 2033.
In Australia, there are nearly 400 domestic biotechnology, 500 MedTech, and 50 multinational companies operating as subsidiaries, including Pfizer, GSK, Bristol-Myers Squibb, Merck, and Novartis. Presence of a large number of local and foreign companies is anticipated to boost manufacturing activities, thereby fueling the market.
Furthermore, aligning with GMPs across various jurisdictions by the Australian Therapeutic Goods Administration (TGA), the U.S. FDA, and the EMA is anticipated to facilitate the market entry of U.S. and European firms in the country.
- Australia Healthcare Contract Development And Manufacturing Organization Market Type Outlook (Revenue, USD MIllion , 2021-2033)
- Small Molecule
- Large Molecule
- Medical Device
- Australia Healthcare Contract Development And Manufacturing Organization Market Product Outlook (Revenue, USD MIllion , 2021-2033)
- Pharmaceutical
- Medical Devices
- Australia Healthcare Contract Development And Manufacturing Organization Market Services Outlook (Revenue, USD MIllion , 2021-2033)
- Contract Development
- Contract Manufacturing
- Packaging and labelling
- Regulatory Affairs
- Others
- Australia Healthcare Contract Development And Manufacturing Organization Market Workflow Outlook (Revenue, USD MIllion , 2021-2033)
- Clinical
- Commercial
- Australia Healthcare Contract Development And Manufacturing Organization Market Therapeutic Area Outlook (Revenue, USD MIllion , 2021-2033)
- Oncology
- Infectious Diseases
- Neurological Disorders
- Cardiovascular Disease
- Metabolic Disorders
- Autoimmune Diseases
- Respiratory Diseases
- Ophthalmology
- Gastrointestinal Disorders
- Orthopedic Diseases
- Dental Diseases
- Others
- Australia Healthcare Contract Development And Manufacturing Organization Market End Use Outlook (Revenue, USD MIllion , 2021-2033)
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
- Others
Reasons to subscribe to Healthcare Contract Development And Manufacturing Organization Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Healthcare Contract Development And Manufacturing Organization Market Outlook databook
- Our clientele includes a mix of Healthcare Contract Development And Manufacturing Organization Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Healthcare Contract Development And Manufacturing Organization Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Healthcare Contract Development And Manufacturing Organization Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Healthcare Contract Development And Manufacturing Organization Market, 2021-2033 (US$M)
Australia Type - Healthcare Contract Development And Manufacturing Organization Market Statistics, 2024 - 2033 (US$M)
